<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE Annotation PUBLIC "-//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN" "../GENIAtypes/GENIA_event_20.dtd">
<Annotation created="26/06/06" annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=10358154" creator="Noriko Katsu">
<PubmedArticleSet>
<PubmedArticle>
<MedlineCitation>
<PMID>10358154</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">New <term sem="Organic_compound_other" id="T1" lex="immunosuppressive_drug">immunosuppressive drug</term> <term sem="Organic_compound_other" id="T2" lex="PNU156804">PNU156804</term> blocks <term id="T3" lex="IL-2-dependent_proliferation"><term sem="Protein_molecule" id="T4" lex="IL-2">IL-2</term>-dependent <term sem="Other" id="A1">proliferation</term></term> and <cons sem="(AND Other Other)" id="T5" lex="(AND NF-kappa_B_activation AP-1_activation)"><frag id="F1"><term sem="Protein_complex" id="A2">NF-kappa B</term></frag> and <frag id="F2"><term sem="Protein_molecule" id="A3">AP-1</term></frag> <frag id="F3">activation</frag></cons>.</sentence>
<event id="E1">
<type class="Negative_regulation" />
<theme idref="E4" />
<cause idref="T2" />
<clue>New immunosuppressive drug PNU156804 <clueType>blocks</clueType> IL-2-dependent proliferation and NF-kappa B and AP-1 activation.</clue>
</event>
<event id="E2">
<type class="Negative_regulation" />
<theme idref="E5" />
<cause idref="T2" />
<clue>New immunosuppressive drug PNU156804 <clueType>blocks</clueType> IL-2-dependent proliferation and NF-kappa B and AP-1 activation.</clue>
</event>
<event id="E3">
<type class="Negative_regulation" />
<theme idref="E6" />
<cause idref="T2" />
<clue>New immunosuppressive drug PNU156804 <clueType>blocks</clueType> IL-2-dependent proliferation and NF-kappa B and AP-1 activation.</clue>
</event>
<event id="E4">
<type class="Regulation" />
<theme idref="A1" />
<clue>New immunosuppressive drug PNU156804 blocks IL-2-<clueType>dependent</clueType> proliferation and NF-kappa B and AP-1 activation.</clue>
<comment>NER: T3 del &quot;IL-2-dependent proliferation&quot;</comment>
</event>
<event id="E5">
<type class="Positive_regulation" />
<theme idref="A2" />
<clue>New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 <clueType>activation</clueType>.</clue>
</event>
<event id="E6">
<type class="Positive_regulation" />
<theme idref="A3" />
<clue>New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 <clueType>activation</clueType>.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">We had previously shown that the drug <term sem="Organic_compound_other" id="T6" lex="undecylprodigiosin">undecylprodigiosin</term> (<term sem="Organic_compound_other" id="T7" lex="UP">UP</term>) blocks <term sem="Other" id="T8" lex="human_lymphocyte_proliferation"><term sem="Cell_natural" id="T9" lex="human_lymphocyte">human lymphocyte</term> proliferation</term> in vitro.</sentence>
<event id="E7">
<type class="Negative_regulation" />
<theme idref="E8" />
<cause idref="T7" />
<clue>We had previously shown that the drug undecylprodigiosin (UP) <clueType>blocks</clueType> human lymphocyte proliferation in vitro.</clue>
</event>
<event id="E8">
<type class="Cellular_physiological_process" />
<theme idref="T9" />
<clue>We had previously shown that the drug undecylprodigiosin (UP) blocks human lymphocyte <clueType>proliferation</clueType> in vitro.</clue>
</event>
<sentence id="S3">We have now investigated the mechanism of action of a new analogue of <term sem="Organic_compound_other" id="T10" lex="UP">UP</term>, <term sem="Organic_compound_other" id="T11" lex="PNU156804">PNU156804</term>, which shows a more favorable <term sem="Other" id="T12" lex="activity_profile">activity profile</term> than <term sem="Organic_compound_other" id="T13" lex="UP">UP</term> in <term sem="Multicellular_organism_natural" id="T14" lex="mouse">mice</term>.</sentence>
<event id="E9">
<type class="Negative_regulation" />
<theme idref="E8" />
<cause idref="T11" />
<clue>We have now investigated the mechanism of action of a new analogue of UP, PNU156804, which <clueType>shows</clueType> a more favorable <clueType>activity profile</clueType> than UP <clueLoc>in mice</clueLoc>.</clue>
<comment>CAUTION: Negative_regulation, from the context in S2</comment>
</event>
<event id="E48">
<type class="Negative_regulation" />
<theme idref="E8" />
<cause idref="T13" />
<clue>We have now investigated the mechanism of action of a new analogue of UP, PNU156804, which <clueType>shows</clueType> a more favorable <clueType>activity profile</clueType> than UP <clueLoc>in mice</clueLoc>.</clue>
<comment>CAUTION: Negative_regulation, from the context in S2</comment>
</event>
<sentence id="S4">We demonstrate here that the biological effect of <term sem="Organic_compound_other" id="T15" lex="PNU156804">PNU156804</term> in vitro is indistinguishable from <term sem="Organic_compound_other" id="T16" lex="UP">UP</term>: <term sem="Organic_compound_other" id="T17" lex="PNU156804">PNU156804</term> blocks <term sem="Other" id="T18" lex="human_T_cell_proliferation"><term sem="Cell_natural" id="T19" lex="human_T_cell">human T cell</term> proliferation</term> in <term sem="Other" id="T20" lex="mid-late_G1">mid-late G1</term>, as determined by <term sem="Other" id="T21" lex="cell_cycle_analysis"><term sem="Other" id="T57" lex="cell_cycle">cell cycle</term> analysis</term>, expression of <term sem="Protein_family_or_group" id="T22" lex="cyclin">cyclins</term>, and <term sem="Protein_family_or_group" id="T23" lex="cyclin-dependent_kinase">cyclin-dependent kinases</term> and <term sem="Other" id="T24" lex="retinoblastoma_phosphorylation"><term sem="Protein_family_or_group" id="A4">retinoblastoma</term> phosphorylation</term>.</sentence>
<event id="E10">
<type class="Negative_regulation" />
<theme idref="E11" />
<cause idref="T17" />
<clue>We demonstrate here that the biological effect of PNU156804 in vitro is indistinguishable from UP: PNU156804 <clueType>blocks</clueType> human T cell proliferation in mid-late G1, as determined by cell cycle analysis, expression of cyclins, and cyclin-dependent kinases and retinoblastoma phosphorylation.</clue>
</event>
<event id="E11">
<type class="Cellular_physiological_process" />
<theme idref="T19" />
<clue>We demonstrate here that the biological effect of PNU156804 in vitro is indistinguishable from UP: PNU156804 blocks human T cell <clueType>proliferation</clueType> in mid-late G1, as determined <clueExperiment>by cell cycle analysis, expression of cyclins, and cyclin-dependent kinases and retinoblastoma phosphorylation</clueExperiment>.</clue>
</event>
<event uncertainty="doubtful" id="E49">
<type class="Cellular_physiological_process" />
<theme idref="T19" />
<clue>We demonstrate here that the biological effect of PNU156804 in vitro is indistinguishable from UP: PNU156804 blocks human T cell proliferation in mid-late G1, as determined by <clueType>cell cycle</clueType> analysis, expression of cyclins, and cyclin-dependent kinases and retinoblastoma phosphorylation.</clue>
</event>
<event uncertainty="doubtful" id="E12">
<type class="Gene_expression" />
<theme idref="T22" />
<clue>We demonstrate here that the biological effect of PNU156804 in vitro is indistinguishable from UP: PNU156804 blocks human T cell proliferation in mid-late G1, as determined by cell cycle analysis, <clueType>expression</clueType> <linkTheme>of</linkTheme> cyclins, and cyclin-dependent kinases and retinoblastoma phosphorylation.</clue>
</event>
<event uncertainty="doubtful" id="E13">
<type class="Protein_amino_acid_phosphorylation" />
<theme idref="T23" />
<clue>We demonstrate here that the biological effect of PNU156804 in vitro is indistinguishable from UP: PNU156804 blocks human T cell proliferation in mid-late G1, as determined by cell cycle analysis, expression of cyclins, and cyclin-dependent kinases and retinoblastoma <clueType>phosphorylation</clueType>.</clue>
</event>
<event uncertainty="doubtful" id="E14">
<type class="Protein_amino_acid_phosphorylation" />
<theme idref="A4" />
<clue>We demonstrate here that the biological effect of PNU156804 in vitro is indistinguishable from UP: PNU156804 blocks human T cell proliferation in mid-late G1, as determined by cell cycle analysis, expression of cyclins, and cyclin-dependent kinases and retinoblastoma <clueType>phosphorylation</clueType>.</clue>
</event>
<event id="E15">
<type class="Negative_regulation" />
<theme idref="E11" />
<cause idref="T16" />
<clue>We demonstrate here that the biological effect of PNU156804 in vitro is indistinguishable from UP: PNU156804 <clueType>blocks</clueType> human T cell proliferation in mid-late G1, as determined by cell cycle analysis, expression of cyclins, and cyclin-dependent kinases and retinoblastoma phosphorylation.</clue>
<comment>CAUTION: SEE, indistinguishable</comment>
</event>
<sentence id="S5">In addition, we show that <term sem="Organic_compound_other" id="T25" lex="PNU156804">PNU156804</term> does not block significantly the induction of either <term sem="Protein_molecule" id="T26" lex="IL-2">IL-2</term> or <cons sem="(AND Protein_molecule Protein_molecule)" id="T27" lex="(AND IL-2R_alpha-chain IL-2R_gamma-chain)"><frag id="F4">IL-2R</frag> <frag id="F5">alpha-</frag> and <frag id="F6">gamma-</frag><frag id="F7">chains</frag></cons> but inhibits <term sem="Other" id="T28" lex="IL-2-dependent_T_cell_proliferation"><term sem="Protein_molecule" id="T29" lex="IL-2">IL-2</term>-dependent <term sem="Cell_natural" id="A5">T cell</term> proliferation</term>.</sentence>
<event assertion="non-exist" id="E16">
<type class="Negative_regulation" />
<theme idref="E19" />
<cause idref="T25" />
<clue>In addition, we show that PNU156804 does not <clueType>block</clueType> significantly the induction of either IL-2 or IL-2R alpha- and gamma-chains but inhibits IL-2-dependent T cell proliferation.</clue>
</event>
<event assertion="non-exist" id="E17">
<type class="Negative_regulation" />
<theme idref="E20" />
<cause idref="T25" />
<clue>In addition, we show that PNU156804 does not <clueType>block</clueType> significantly the induction of either IL-2 or IL-2R alpha- and gamma-chains but inhibits IL-2-dependent T cell proliferation.</clue>
</event>
<event assertion="non-exist" id="E18">
<type class="Negative_regulation" />
<theme idref="E21" />
<cause idref="T25" />
<clue>In addition, we show that PNU156804 does not <clueType>block</clueType> significantly the induction of either IL-2 or IL-2R alpha- and gamma-chains but inhibits IL-2-dependent T cell proliferation.</clue>
</event>
<event id="E19">
<type class="Positive_regulation" />
<theme idref="T26" />
<clue>In addition, we show that PNU156804 does not block significantly the <clueType>induction</clueType> <linkTheme>of</linkTheme> either IL-2 or IL-2R alpha- and gamma-chains but inhibits IL-2-dependent T cell proliferation.</clue>
</event>
<event id="E20">
<type class="Positive_regulation" />
<theme idref1="F5" idref2="F7" idref="F4" />
<clue>In addition, we show that PNU156804 does not block significantly the <clueType>induction</clueType> <linkTheme>of</linkTheme> either IL-2 or IL-2R alpha- and gamma-chains but inhibits IL-2-dependent T cell proliferation.</clue>
</event>
<event id="E21">
<type class="Positive_regulation" />
<theme idref1="F6" idref2="F7" idref="F4" />
<clue>In addition, we show that PNU156804 does not block significantly the <clueType>induction</clueType> <linkTheme>of</linkTheme> either IL-2 or IL-2R alpha- and gamma-chains but inhibits IL-2-dependent T cell proliferation.</clue>
</event>
<event id="E22">
<type class="Negative_regulation" />
<theme idref="E23" />
<cause idref="T25" />
<clue>In addition, we show that PNU156804 does not block significantly the induction of either IL-2 or IL-2R alpha- and gamma-chains but <clueType>inhibits</clueType> IL-2-dependent T cell proliferation.</clue>
</event>
<event id="E23">
<type class="Regulation" />
<theme idref="E24" />
<cause idref="T29" />
<clue>In addition, we show that PNU156804 does not block significantly the induction of either IL-2 or IL-2R alpha- and gamma-chains but inhibits IL-2-<clueType>dependent</clueType> T cell proliferation.</clue>
</event>
<event id="E24">
<type class="Cellular_physiological_process" />
<theme idref="A5" />
<clue>In addition, we show that PNU156804 does not block significantly the induction of either IL-2 or IL-2R alpha- and gamma-chains but inhibits IL-2-dependent T cell <clueType>proliferation</clueType>.</clue>
</event>
<sentence id="S6">We have investigated several <term sem="Other" id="T30" lex="molecular_pathway">molecular pathways</term> that are known to be activated by <term sem="Protein_molecule" id="T31" lex="IL-2">IL-2</term> in <term sem="Cell_natural" id="T32" lex="T_cell">T cells</term>.</sentence>
<event id="E25">
<type class="Positive_regulation" />
<theme idref="T30" />
<cause idref="T31" />
<clue>We have investigated several molecular pathways that are known to be <clueType>activated</clueType> <linkCause>by</linkCause> IL-2 <clueLoc>in T cells</clueLoc>.</clue>
</event>
<sentence id="S7">We show that <term sem="Organic_compound_other" id="T33" lex="PNU156804">PNU156804</term> does not inhibit <cons sem="(AND Other Other)" id="T34" lex="(AND c-myc_mRNA_induction bcl-2_mRNA_induction)"><frag id="F8"><term sem="RNA_molecule" id="A10">c-myc</term></frag> and <frag id="F9"><term sem="RNA_molecule" id="A11">bcl-2</term></frag> <frag id="F10"><term sem="RNA_molecule" id="A12">mRNA</term> induction</frag></cons>.</sentence>
<event assertion="non-exist" id="E26">
<type class="Negative_regulation" />
<theme idref="E28" />
<cause idref="T33" />
<clue>We show that PNU156804 does not <clueType>inhibit</clueType> c-myc and bcl-2 mRNA induction.</clue>
</event>
<event assertion="non-exist" id="E27">
<type class="Negative_regulation" />
<theme idref="E29" />
<cause idref="T33" />
<clue>We show that PNU156804 does not <clueType>inhibit</clueType> c-myc and bcl-2 mRNA induction.</clue>
</event>
<event id="E28">
<type class="Positive_regulation" />
<theme idref1="A12" idref="A10" />
<clue>We show that PNU156804 does not inhibit c-myc and bcl-2 mRNA <clueType>induction</clueType>.</clue>
</event>
<event id="E29">
<type class="Positive_regulation" />
<theme idref1="A12" idref="A11" />
<clue>We show that PNU156804 does not inhibit c-myc and bcl-2 mRNA <clueType>induction</clueType>.</clue>
</event>
<sentence id="S8">On the other hand, <term sem="Organic_compound_other" id="T35" lex="PNU156804">PNU156804</term> efficiently inhibits the activation of the <term sem="Protein_complex" id="T36" lex="NF-kappa_B">NF-kappa B</term> and <term sem="Protein_molecule" id="T37" lex="AP-1">AP-1</term> transcription factors.</sentence>
<event id="E30">
<type class="Negative_regulation" />
<theme idref="E32" />
<cause idref="T35" />
<clue>On the other hand, PNU156804 efficiently <clueType>inhibits</clueType> the activation of the NF-kappa B and AP-1 transcription factors.</clue>
</event>
<event id="E31">
<type class="Negative_regulation" />
<theme idref="E33" />
<cause idref="T35" />
<clue>On the other hand, PNU156804 efficiently <clueType>inhibits</clueType> the activation of the NF-kappa B and AP-1 transcription factors.</clue>
</event>
<event id="E32">
<type class="Positive_regulation" />
<theme idref="T36" />
<clue>On the other hand, PNU156804 efficiently inhibits the <clueType>activation</clueType> <linkTheme>of</linkTheme> the NF-kappa B and AP-1 transcription factors.</clue>
</event>
<event id="E33">
<type class="Positive_regulation" />
<theme idref="T37" />
<clue>On the other hand, PNU156804 efficiently inhibits the <clueType>activation</clueType> <linkTheme>of</linkTheme> the NF-kappa B and AP-1 transcription factors.</clue>
</event>
<sentence id="S9"><term sem="Organic_compound_other" id="T38" lex="PNU156804">PNU156804</term> inhibition of <term sem="Protein_complex" id="T39" lex="NF-kappa_B">NF-kappa B</term> activation is due to the inhibition of the degradation of <term sem="Protein_molecule" id="T40" lex="I_kappa_B-alpha">I kappa B-alpha</term> and <term sem="Protein_molecule" id="T41" lex="I_kappa_B-beta">I kappa B-beta</term>.</sentence>
<event id="E34">
<type class="Negative_regulation" />
<theme idref="E35" />
<cause idref="T38" />
<clue>PNU156804 <clueType>inhibition</clueType> <linkTheme>of</linkTheme> NF-kappa B activation is due to the inhibition of the degradation of I kappa B-alpha and I kappa B-beta.</clue>
</event>
<event id="E35">
<type class="Positive_regulation" />
<theme idref="T39" />
<clue>PNU156804 inhibition of NF-kappa B <clueType>activation</clueType> is due to the inhibition of the degradation of I kappa B-alpha and I kappa B-beta.</clue>
</event>
<event id="E36">
<type class="Positive_regulation" />
<theme idref="E34" />
<cause idref="E38" />
<clue>PNU156804 inhibition of NF-kappa B activation is <clueType>due</clueType> <linkCause>to</linkCause> the inhibition of the degradation of I kappa B-alpha and I kappa B-beta.</clue>
</event>
<event id="E37">
<type class="Positive_regulation" />
<theme idref="E34" />
<cause idref="E39" />
<clue>PNU156804 inhibition of NF-kappa B activation is <clueType>due</clueType> <linkCause>to</linkCause> the inhibition of the degradation of I kappa B-alpha and I kappa B-beta.</clue>
</event>
<event id="E38">
<type class="Negative_regulation" />
<theme idref="E40" />
<cause idref="T38" />
<clue>PNU156804 inhibition of NF-kappa B activation is due to the <clueType>inhibition</clueType> <linkTheme>of</linkTheme> the degradation of I kappa B-alpha and I kappa B-beta.</clue>
</event>
<event id="E39">
<type class="Negative_regulation" />
<theme idref="E41" />
<cause idref="T38" />
<clue>PNU156804 inhibition of NF-kappa B activation is due to the <clueType>inhibition</clueType> <linkTheme>of</linkTheme> the degradation of I kappa B-alpha and I kappa B-beta.</clue>
</event>
<event id="E40">
<type class="Protein_catabolism" />
<theme idref="T40" />
<clue>PNU156804 inhibition of NF-kappa B activation is due to the inhibition of the <clueType>degradation</clueType> <linkTheme>of</linkTheme> I kappa B-alpha and I kappa B-beta.</clue>
</event>
<event id="E41">
<type class="Protein_catabolism" />
<theme idref="T41" />
<clue>PNU156804 inhibition of NF-kappa B activation is due to the inhibition of the <clueType>degradation</clueType> <linkTheme>of</linkTheme> I kappa B-alpha and I kappa B-beta.</clue>
</event>
<sentence id="S10"><term sem="Organic_compound_other" id="T42" lex="PNU156804">PNU156804</term> action is restricted to some <term sem="Other" id="T43" lex="signaling_pathway">signaling pathways</term>; it does not affect <term sem="Other" id="T44" lex="NF-kappa_B_activation"><term sem="Protein_complex" id="T45" lex="NF-kappa_B">NF-kappa B</term> activation</term> by <term sem="Organic_compound_other" id="T46" lex="PMA">PMA</term> in <term sem="Cell_natural" id="T47" lex="T_cell">T cells</term> but blocks that induced by <term sem="Other" id="T48" lex="CD40_cross-linking"><term sem="Protein_molecule" id="T49" lex="CD40">CD40</term> cross-linking</term> in <term sem="Cell_natural" id="T50" lex="B_lymphocyte">B lymphocytes</term>.</sentence>
<event id="E42">
<type class="Regulation" />
<theme idref="T43" />
<cause idref="T42" />
<clue>PNU156804 <clueType>action</clueType> is restricted <linkTheme>to</linkTheme> some signaling pathways; it does not affect NF-kappa B activation by PMA in T cells but blocks that induced by CD40 cross-linking in B lymphocytes.</clue>
</event>
<event assertion="non-exist" id="E43">
<type class="Regulation" />
<theme idref="E44" />
<cause idref="T42" />
<clue>PNU156804 action is restricted to some signaling pathways; it does not <clueType>affect</clueType> NF-kappa B activation by PMA in T cells but blocks that induced by CD40 cross-linking in B lymphocytes.</clue>
</event>
<event id="E44">
<type class="Positive_regulation" />
<theme idref="T45" />
<cause idref="T46" />
<clue>PNU156804 action is restricted to some signaling pathways; it does not affect NF-kappa B <clueType>activation</clueType> <linkCause>by</linkCause> PMA <clueLoc>in T cells</clueLoc> but blocks that induced by CD40 cross-linking in B lymphocytes.</clue>
</event>
<event id="E45">
<type class="Negative_regulation" />
<theme idref="E46" />
<cause idref="T42" />
<clue>PNU156804 action is restricted to some signaling pathways; it does not affect NF-kappa B activation by PMA in T cells but <clueType>blocks</clueType> that induced by CD40 cross-linking in B lymphocytes.</clue>
</event>
<event id="E46">
<type class="Positive_regulation" />
<theme idref="T45" />
<cause idref="E47" />
<clue>PNU156804 action is restricted to some signaling pathways; it does not affect NF-kappa B activation by PMA in T cells but blocks <corefTheme>that</corefTheme> <clueType>induced</clueType> <linkCause>by</linkCause> CD40 cross-linking <clueLoc>in B lymphocytes</clueLoc>.</clue>
</event>
<event id="E47">
<type class="Binding" />
<theme idref="T49" />
<clue>PNU156804 action is restricted to some signaling pathways; it does not affect NF-kappa B activation by PMA in T cells but blocks that induced by CD40 <clueType>cross-linking</clueType> in B lymphocytes.</clue>
</event>
<sentence id="S11">We conclude that the <term sem="Organic_compound_other" id="T51" lex="prodigiosin_family">prodigiosin family</term> of <term sem="Organic_compound_other" id="T52" lex="immunosuppressant">immunosuppressants</term> is a new family of molecules that show a novel target specificity clearly distinct from that of other <term sem="Organic_compound_other" id="T53" lex="immunosuppressive_drug">immunosuppressive drugs</term> such as <term sem="Organic_compound_other" id="T54" lex="cyclosporin_A">cyclosporin A</term>, <term sem="Organic_compound_other" id="T55" lex="FK506">FK506</term>, and <term sem="Organic_compound_other" id="T56" lex="rapamycin">rapamycin</term>.</sentence>
</AbstractText>
</Abstract>
</Article>
</MedlineCitation>
</PubmedArticle>
</PubmedArticleSet>
</Annotation>
